Author Correction: Crizotinib-induced immunogenic cell death in non-small cell lung cancer

被引:0
|
作者
Peng Liu
Liwei Zhao
Jonathan Pol
Sarah Levesque
Adriana Petrazzuolo
Christina Pfirschke
Camilla Engblom
Steffen Rickelt
Takahiro Yamazaki
Kristina Iribarren
Laura Senovilla
Lucillia Bezu
Erika Vacchelli
Valentina Sica
Andréa Melis
Tiffany Martin
Lin Xia
Heng Yang
Qingqing Li
Jinfeng Chen
Sylvère Durand
Fanny Aprahamian
Deborah Lefevre
Sophie Broutin
Angelo Paci
Amaury Bongers
Veronique Minard-Colin
Eric Tartour
Laurence Zitvogel
Lionel Apetoh
Yuting Ma
Mikael J. Pittet
Oliver Kepp
Guido Kroemer
机构
[1] University of Paris Sud,Faculty of Medicine
[2] Cell Biology and Metabolomics Platforms,Department of Radiation Oncology
[3] Gustave Roussy Cancer Campus,Department of Anaesthesiology
[4] Equipe 11 labellisée Ligue Nationale contre le Cancer,Department of Medical Oncology
[5] Centre de Recherche des Cordeliers,Department of Pharmacology
[6] Institut National de la Santé et de la Recherche Médicale,Department of Immunology
[7] UMR1138,Department of Radiology
[8] Equipe labellisée Ligue Nationale Contre le Cancer,Department of Women’s and Children’s Health
[9] Université Paris Descartes,undefined
[10] Sorbonne Paris Cité,undefined
[11] Université Pierre et Marie Curie,undefined
[12] Center for Systems Biology,undefined
[13] Massachusetts General Hospital Research Institute and Harvard Medical School,undefined
[14] Graduate Program in Immunology,undefined
[15] Harvard Medical School,undefined
[16] Koch Institute for Integrative Cancer Research,undefined
[17] Massachusetts Institute of Technology,undefined
[18] Weill Cornell Medical College,undefined
[19] Hôpital Européen Georges Pompidou,undefined
[20] Centre de Recherche INSERM LNC-,undefined
[21] Centre Georges-François Leclerc,undefined
[22] Center for Systems Medicine,undefined
[23] Institute of Basic Medical Sciences,undefined
[24] Chinese Academy of Medical Sciences and Peking Union Medical College,undefined
[25] Suzhou Institute of Systems Medicine,undefined
[26] Institut Gustave Roussy,undefined
[27] School of Pharmacy,undefined
[28] Université Paris Sud,undefined
[29] Institut de Cancérologie,undefined
[30] Gustave Roussy Cancer Campus (GRCC),undefined
[31] INSERM U970,undefined
[32] Université Paris Descartes Sorbonne Paris-Cité,undefined
[33] Hôpital Européen Georges Pompidou,undefined
[34] INSERM U1015,undefined
[35] Center of Clinical Investigations CIC1428,undefined
[36] Massachusetts General Hospital,undefined
[37] Pôle de Biologie,undefined
[38] Hôpital Européen Georges Pompidou,undefined
[39] AP-HP,undefined
[40] Karolinska University Hospital,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The original version of this Article contained an error in the spelling of the author Lin Xia, which was incorrectly given as Xia Lin. This has now been corrected in both the PDF and HTML versions of the Article.
引用
收藏
相关论文
共 50 条
  • [1] Crizotinib-induced immunogenic cell death in non-small cell lung cancer
    Peng Liu
    Liwei Zhao
    Jonathan Pol
    Sarah Levesque
    Adriana Petrazzuolo
    Christina Pfirschke
    Camilla Engblom
    Steffen Rickelt
    Takahiro Yamazaki
    Kristina Iribarren
    Laura Senovilla
    Lucillia Bezu
    Erika Vacchelli
    Valentina Sica
    Andréa Melis
    Tiffany Martin
    Lin Xia
    Heng Yang
    Qingqing Li
    Jinfeng Chen
    Sylvère Durand
    Fanny Aprahamian
    Deborah Lefevre
    Sophie Broutin
    Angelo Paci
    Amaury Bongers
    Veronique Minard-Colin
    Eric Tartour
    Laurence Zitvogel
    Lionel Apetoh
    Yuting Ma
    Mikael J. Pittet
    Oliver Kepp
    Guido Kroemer
    [J]. Nature Communications, 10
  • [2] Crizotinib-induced immunogenic cell death in non-small cell lung cancer
    Liu, Peng
    Zhao, Liwei
    Pol, Jonathan
    Levesque, Sarah
    Petrazzuolo, Adriana
    Pfirschke, Christina
    Engblom, Camilla
    Rickelt, Steffen
    Yamazaki, Takahiro
    Iribarren, Kristina
    Senovilla, Laura
    Bezu, Lucillia
    Vacchelli, Erika
    Sica, Valentina
    Melis, Andrea
    Martin, Tiffany
    Lin, Xia
    Yang, Heng
    Li, Qingqing
    Chen, Jinfeng
    Durand, Sylvere
    Aprahamian, Fanny
    Lefevre, Deborah
    Broutin, Sophie
    Paci, Angelo
    Bongers, Amaury
    Minard-Colin, Veronique
    Tartour, Eric
    Zitvogel, Laurence
    Apetoh, Lionel
    Ma, Yuting
    Pittet, Mikael J.
    Kepp, Oliver
    Kroemer, Guido
    [J]. NATURE COMMUNICATIONS, 2019, 10 (1)
  • [3] Crizotinib-induced immunogenic cell death in non-small cell lung cancer (vol 10, 1486, 2019)
    Liu, Peng
    Zhao, Liwei
    Pol, Jonathan
    Levesque, Sarah
    Petrazzuolo, Adriana
    Pfirschke, Christina
    Engblom, Camilla
    Rickelt, Steffen
    Yamazaki, Takahiro
    Iribarren, Kristina
    Senovilla, Laura
    Bezu, Lucillia
    Vacchelli, Erika
    Sica, Valentina
    Melis, Andrea
    Martin, Tiffany
    Xia, Lin
    Yang, Heng
    Li, Qingqing
    Chen, Jinfeng
    Durand, Sylvere
    Aprahamian, Fanny
    Lefevre, Deborah
    Broutin, Sophie
    Paci, Angelo
    Bongers, Amaury
    Minard-Colin, Veronique
    Tartour, Eric
    Zitvogel, Laurence
    Apetoh, Lionel
    Ma, Yuting
    Pittet, Mikael J.
    Kepp, Oliver
    Kroemer, Guido
    [J]. NATURE COMMUNICATIONS, 2019, 10 (1)
  • [4] Factors affecting crizotinib-induced hepatotoxicity in non-small cell lung cancer patients
    Dasom Jung
    Ji Min Han
    Jeong Yee
    Jae Youn Kim
    Hye Sun Gwak
    [J]. Medical Oncology, 2018, 35
  • [5] Factors affecting crizotinib-induced hepatotoxicity in non-small cell lung cancer patients
    Jung, Dasom
    Han, Ji Min
    Yee, Jeong
    Kim, Jae Youn
    Gwak, Hye Sun
    [J]. MEDICAL ONCOLOGY, 2018, 35 (12)
  • [6] Successful treatment of crizotinib-induced dysgeusia by switching to alectinib in ALK-positive non-small cell lung cancer
    Koizumi, Tomonobu
    Fukushima, Toshirou
    Tatai, Toshiharu
    Kobayashi, Takashi
    Sekiguchi, Nodoka
    Sakamoto, Akiyuki
    Sasaki, Shigeru
    [J]. LUNG CANCER, 2015, 88 (01) : 112 - 113
  • [7] Crizotinib (Xalkori) for Non-Small Cell Lung Cancer
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2012, 54 (1383): : 11 - 12
  • [8] Successful Crizotinib Rechallenge after Crizotinib-Induced Organizing Pneumonia in Anaplastic Lymphoma Kinase-Rearranged Non-Small Cell Lung Cancer
    Asai, Nobuhiro
    Yokoi, Toyoharu
    Yamaguchi, Etsuro
    Kubo, Akihito
    [J]. CASE REPORTS IN ONCOLOGY, 2014, 7 (03): : 681 - 684
  • [9] Entrectinib for ROS1-rearranged non-small cell lung cancer after crizotinib-induced interstitial lung disease: A case report
    Tanimura, Mai
    Kataoka, Nobutaka
    Kunimatsu, Yusuke
    Tsutsumi, Rei
    Sato, Izumi
    Nakano, Takayuki
    Tanimura, Keiko
    Takeda, Takayuki
    [J]. RESPIROLOGY CASE REPORTS, 2021, 9 (11):
  • [10] Impact of STAT1 polymorphisms on crizotinib-induced hepatotoxicity in ALK-positive non-small cell lung cancer patients
    Xin, Shuang
    Fang, Wenfeng
    Li, Jianwen
    Li, Delan
    Wang, Changzheng
    Huang, Quanfei
    Huang, Min
    Zhuang, Wei
    Wang, Xueding
    Chen, Likun
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (03) : 725 - 737